Suppr超能文献

肠致病性大肠杆菌效应因子 EspG1/G2 破坏紧密连接:新的作用和机制。

Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

机构信息

Section of Digestive Diseases and Nutrition, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.

出版信息

Ann N Y Acad Sci. 2012 Jul;1258:149-58. doi: 10.1111/j.1749-6632.2012.06563.x.

Abstract

Enteropathogenic E. coli (EPEC) infection is a major cause of infantile diarrhea in the developing world. Using a type-three secretion system, bacterial effector proteins are transferred to the host cell cytosol where they affect multiple physiological functions, ultimately leading to diarrheal disease. Disruption of intestinal epithelial cell tight junctions is a major consequence of EPEC infection and is mediated by multiple effector proteins, among them EspG1 and its homologue EspG2. EspG1/G2 contribute to loss of barrier function via an undefined mechanism that may be linked to their disruption of microtubule networks. Recently new investigations have identified additional roles for EspG. Sequestration of active ADP-ribosylating factor (ARF) proteins and promotion of p21-activated kinase (PAK) activity as well as inhibition of Golgi-mediated protein secretion have all been linked to EspG. In this review, we examine the functions of EspG1/G2 and discuss potential mechanisms of EspG-mediated tight junction disruption.

摘要

肠致病性大肠杆菌(EPEC)感染是发展中国家婴儿腹泻的主要原因。细菌效应蛋白通过 III 型分泌系统转移到宿主细胞质中,影响多种生理功能,最终导致腹泻病。破坏肠上皮细胞紧密连接是 EPEC 感染的主要后果,由多种效应蛋白介导,其中包括 EspG1 和其同源物 EspG2。EspG1/G2 通过一种未知的机制导致屏障功能丧失,该机制可能与其破坏微管网络有关。最近的新研究确定了 EspG 的其他作用。EspG 可隔离活性 ADP-核糖基转移酶(ARF)蛋白并促进 p21 激活激酶(PAK)活性,同时抑制高尔基介导的蛋白质分泌。在这篇综述中,我们研究了 EspG1/G2 的功能,并讨论了 EspG 介导的紧密连接破坏的潜在机制。

相似文献

1
Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.
Ann N Y Acad Sci. 2012 Jul;1258:149-58. doi: 10.1111/j.1749-6632.2012.06563.x.
4
Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability.
Infect Immun. 2005 Oct;73(10):6283-9. doi: 10.1128/IAI.73.10.6283-6289.2005.
5
Function and distribution of EspG2, a type III secretion system effector of enteropathogenic Escherichia coli.
Microbes Infect. 2006 Jul;8(8):2220-7. doi: 10.1016/j.micinf.2006.04.004. Epub 2006 May 24.
8
Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.
Front Cell Infect Microbiol. 2016 Aug 24;6:87. doi: 10.3389/fcimb.2016.00087. eCollection 2016.
9
The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.
Cell Microbiol. 2010 Jan;12(1):31-41. doi: 10.1111/j.1462-5822.2009.01376.x. Epub 2009 Aug 27.

引用本文的文献

2
Models of the Small Intestine for Studying Intestinal Diseases.
Front Microbiol. 2022 Jan 4;12:767038. doi: 10.3389/fmicb.2021.767038. eCollection 2021.
3
Virulence factors impair epithelial junctions during bacterial infection.
J Clin Lab Anal. 2021 Feb;35(2):e23627. doi: 10.1002/jcla.23627. Epub 2020 Oct 17.
6
Influence of CNCM I-745on the gut-associated immune system.
Clin Exp Gastroenterol. 2016 Sep 13;9:269-279. doi: 10.2147/CEG.S111003. eCollection 2016.
7
How Bacteria Subvert Animal Cell Structure and Function.
Annu Rev Cell Dev Biol. 2016 Oct 6;32:373-397. doi: 10.1146/annurev-cellbio-100814-125227. Epub 2016 May 4.
8
Mechanisms of DRA recycling in intestinal epithelial cells: effect of enteropathogenic E. coli.
Am J Physiol Cell Physiol. 2015 Dec 15;309(12):C835-46. doi: 10.1152/ajpcell.00107.2015. Epub 2015 Oct 7.
10
Republished: tracing PAKs from GI inflammation to cancer.
Postgrad Med J. 2014 Nov;90(1069):657-68. doi: 10.1136/postgradmedj-2014-306768rep.

本文引用的文献

3
Environmental toxicants and male reproductive function.
Spermatogenesis. 2011 Jan;1(1):2-13. doi: 10.4161/spmg.1.1.13971.
4
EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.
Cell Microbiol. 2011 Sep;13(9):1429-39. doi: 10.1111/j.1462-5822.2011.01631.x. Epub 2011 Jul 11.
6
Honing the message: post-transcriptional and post-translational control in attaching and effacing pathogens.
Trends Microbiol. 2011 May;19(5):217-24. doi: 10.1016/j.tim.2011.01.004. Epub 2011 Feb 18.
7
STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.
Inflamm Bowel Dis. 2011 Nov;17(11):2224-34. doi: 10.1002/ibd.21628. Epub 2011 Feb 9.
8
Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase.
Biochemistry. 2011 Feb 15;50(6):917-9. doi: 10.1021/bi1020138. Epub 2011 Jan 24.
9
Redistribution of tight junction proteins during EPEC infection in vivo.
Inflammation. 2012 Feb;35(1):23-32. doi: 10.1007/s10753-010-9285-1.
10
The assembly of a GTPase-kinase signalling complex by a bacterial catalytic scaffold.
Nature. 2011 Jan 6;469(7328):107-11. doi: 10.1038/nature09593. Epub 2010 Dec 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验